Auf dieser Seite
VMD Viemed Healthcare, Inc. - Common Shares
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 3, 2026
$9,13
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$6,0552-Wochen-Tief
$12,6152-Wochen-Hoch
Marktkapitalisierung (MRQ)
$348M
P/E (TTM)
25.4
EPS (TTM)
$0.36
Umsatz (TTM)
$302M
Ihre Abzeichen
52W-Spanne
$6–$13
Analystenbewertung
BUY
Kursziel
$12
P/E
25.4
ROE
10.2%
Nettogewinnmarge
4.8%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
VMD Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$9.13
Marktkapitalisierung (MRQ)
$348M
P/E (TTM)
25.4
EPS (TTM)
$0.36
Umsatz (TTM)
$302M
ROE (TTM)
10.2%
Verschuldungsgrad (MRQ)
0.0
52W-Spanne
$6–$13
VMD Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$270M2019-12-31 → 2025-12-31
EPS$0.372019-12-31 → 2025-12-31
Freier Cashflow$12M2020-12-31 → 2025-12-31
Nettogewinnmarge4.8%2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | VMD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 25.45-Jahres-Durchschnitt ≈30.2 | ≈30.2 | 18.9 | Überbewertet | |
| P/S (TTM) | 1.25-Jahres-Durchschnitt ≈1.6 | ≈1.6 | 2.3 | Unterbewertet | |
| K/B (MRQ) | 2.45-Jahres-Durchschnitt ≈2.4 | ≈2.4 | 3.0 | Fairer Wert | |
| EV / EBITDA | 6.85-Jahres-Durchschnitt ≈13.9 | ≈13.9 | · | · | |
| Kurs / FCF (TTM) | 11.95-Jahres-Durchschnitt ≈82.4 | ≈82.4 | · | · | |
| Kurs / Cashflow (TTM) | 5.75-Jahres-Durchschnitt ≈7.9 | ≈7.9 | · | · | |
| EV / Revenue (EV / Umsatz) | 1.35-Jahres-Durchschnitt ≈1.5 | ≈1.5 | · | · | |
| EV / FCF | 29.45-Jahres-Durchschnitt ≈78.0 | ≈78.0 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 2.45-Jahres-Durchschnitt ≈3.1 | ≈3.1 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | VMD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 57.5%5-Jahres-Durchschnitt ≈60.5% | ≈60.5% | · | · | |
| Betriebsgewinnmarge (TTM) | 7.5%5-Jahres-Durchschnitt ≈8.0% | ≈8.0% | -8.3% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 17.6%5-Jahres-Durchschnitt ≈14.8% | ≈14.8% | -8.3% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 7.0%5-Jahres-Durchschnitt ≈8.1% | ≈8.1% | -12.8% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 4.8%5-Jahres-Durchschnitt ≈5.7% | ≈5.7% | -11.9% | Spitzenklasse | |
| ROA (TTM) | 7.5%5-Jahres-Durchschnitt ≈7.1% | ≈7.1% | 0.70% | Spitzenklasse | |
| ROE (TTM) | 10.2%5-Jahres-Durchschnitt ≈9.2% | ≈9.2% | 10.9% | Im Einklang | |
| ROIC | 10.5%5-Jahres-Durchschnitt ≈8.5% | ≈8.5% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | VMD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.0 | Im Einklang | |
| Liquiditätsgrad (MRQ) | 1.15-Jahres-Durchschnitt ≈1.7 | ≈1.7 | 1.0 | Im Einklang | |
| Quick Ratio | 1.05-Jahres-Durchschnitt ≈1.4 | ≈1.4 | 0.8 | Starke Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | VMD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 20.5%5-Jahres-Durchschnitt ≈16.5% | ≈16.5% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 24.9%5-Jahres-Durchschnitt ≈20.3% | ≈20.3% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 15.5% | · | · | · | |
| EPS YoY (EPS VjV) | 32.1%5-Jahres-Durchschnitt ≈0.27% | ≈0.27% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 32.6%5-Jahres-Durchschnitt ≈0.86% | ≈0.86% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 32.2%5-Jahres-Durchschnitt ≈3.0% | ≈3.0% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -13.9% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 33.9%5-Jahres-Durchschnitt ≈3.3% | ≈3.3% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -13.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | VMD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.45-Jahres-Durchschnitt ≈1.3 | ≈1.3 | 1.0 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 24.55-Jahres-Durchschnitt ≈19.7 | ≈19.7 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 10.75-Jahres-Durchschnitt ≈10.2 | ≈10.2 | 10.7 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$188.0K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-11.4%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $0.07 | $0.12 | -42.2% |
| 31. März 2026 | $0.06 | $0.09 | -34.0% | |
| 31. Dezember 2025 | $0.14 | $0.13 | 10.8% | |
| 30. September 2025 | $0.09 | $0.09 | -0.99% | |
| 30. Juni 2025 | $0.08 | $0.08 | -0.99% | |
| 31. März 2025 | $0.06 | $0.06 | -0.99% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $270M | $224M | $183M | $139M | $117M | $131M | $80M | $64M | |
| Cost of Revenue | $115M | $91M | $70M | $54M | $44M | $51M | $24M | $17M | |
| Gross Profit | $155M | $133M | $113M | $85M | $73M | $80M | $56M | $48M | |
| R&D Expense | $3M | $3M | $3M | $3M | $2M | $1M | $848.0K | $0 | |
| SG&A Expense | $121M | $106M | $88M | $68M | $55M | $53M | $41M | $34M | |
| Operating Income | $23M | $18M | $14M | $8M | $12M | $27M | $9M | $10M | |
| Other Non-op | $252.0K | $-173.0K | $98.0K | $989.0K | $2M | $4M | $-3.0K | · | |
| Pretax Income | $22M | $16M | $14M | $9M | $13M | $26M | $9M | $10M | |
| Income Tax | $6M | $5M | $4M | $3M | $3M | $-5M | $271.0K | $162.0K | |
| Net Income | $15M | $11M | $10M | $6M | $9M | $32M | $9M | $10M | |
| EPS (Basic) | $0.38 | $0.29 | $0.27 | $0.16 | $0.23 | $0.81 | $0.23 | $0.25 | |
| EPS (Diluted) | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 | $0.78 | $0.21 | $0.24 | |
| Shares (Basic) | 38,895,228 | 38,754,893 | 38,354,071 | 38,655,403 | 39,491,117 | 38,743,516 | 37,716,864 | 37,892,118 | |
| Shares (Diluted) | 40,823,823 | 40,805,085 | 40,378,922 | 39,807,434 | 40,680,947 | 40,525,737 | 39,747,509 | 39,677,704 | |
| EBITDA | $52M | $43M | $36M | $8M | $12M | $27M | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $14M | $18M | $13M | $17M | $28M | $31M | $13M | $10M | |
| Receivables | $26M | $25M | $18M | $15M | $13M | $12M | $12M | $9M | |
| Inventory | $5M | $4M | $5M | $4M | $2M | $2M | $1M | $3M | |
| Prepaid Expense | $4M | $6M | $2M | $4M | $2M | $2M | $2M | $952.0K | |
| Current Assets | $48M | $53M | $38M | $40M | $47M | $47M | $28M | $23M | |
| PP&E (Net) | $79M | $76M | $74M | $68M | $63M | $55M | $55M | $31M | |
| Accum. Depreciation | $61M | $58M | $53M | $40M | $28M | $20M | $14M | $9M | |
| Goodwill | $59M | $33M | $30M | $0 | · | · | · | · | |
| Intangibles | $1M | $848.0K | $567.0K | $0 | · | · | · | · | |
| Other Non-current Assets | · | $0 | $887.0K | $2M | $862.0K | $863.0K | $0 | $0 | |
| Total Assets | $199M | $177M | $155M | $117M | $118M | $113M | $83M | $54M | |
| Accounts Payable | · | · | · | · | · | · | $2M | $1M | |
| Accrued Liabilities | $24M | $20M | $18M | $11M | $9M | $13M | $9M | $8M | |
| Current Liabilities | $41M | $37M | $32M | $19M | $18M | $23M | $26M | $20M | |
| Capital Leases | $2M | $2M | $2M | $199.0K | · | · | · | · | |
| Total Liabilities | $56M | $44M | $41M | $20M | $23M | $31M | $39M | $21M | |
| Long-term Debt | $12M | $4M | $7M | $0 | $6M | $8M | $9M | $0 | |
| Total Debt | $12M | $4M | $7M | $0 | $6M | $8M | · | · | |
| Common Stock | $17M | $23M | $19M | $15M | $14M | $9M | $3M | $71.0K | |
| Retained Earnings | $103M | $90M | $79M | $70M | $73M | $66M | $34M | $27M | |
| AOCI | · | · | · | $0 | $-278.0K | $-451.0K | $-157.0K | $0 | |
| Stockholders' Equity | $142M | $131M | $114M | $97M | $95M | $82M | $44M | $33M | |
| Liabilities + Equity | $199M | $177M | $155M | $117M | $118M | $113M | $83M | $54M | |
| Shares Outstanding | 38,019,082 | 39,132,897 | 38,506,161 | 38,049,739 | 39,640,388 | 39,185,182 | 37,952,660 | 37,500,815 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $29M | $25M | $22M | $16M | · | · | · | · | |
| Stock-based Comp | $9M | $6M | $6M | $5M | $5M | $5M | $4M | $3M | |
| Deferred Tax | $3M | $-4M | $-1M | $2M | $4M | $-9M | $0 | $0 | |
| Amort. of Intangibles | $200.0K | $100.0K | $100.0K | · | · | · | · | · | |
| Other Non-cash | $-4M | $11.0K | $9M | · | · | · | · | · | |
| Operating Cash Flow | $52M | $39M | $45M | $28M | $22M | $35M | $19M | $22M | |
| CapEx | $40M | $38M | $26M | $23M | $20M | $13M | $13M | $6M | |
| Investing Cash Flow | $-50M | $-31M | $-52M | $-24M | $-20M | $-8M | $-13M | $-5M | |
| Debt Issued | · | · | · | · | · | · | $5M | $0 | |
| Stock Repurchased | $13M | $0 | $0 | $10M | $0 | $0 | $2M | $2M | |
| Net Stock Activity | $-13M | $0 | $0 | $-10M | $-1M | $0 | · | · | |
| Financing Cash Flow | $-6M | $-4M | $3M | $-15M | $-5M | $-9M | $-3M | $-12M | |
| Net Change in Cash | $-4M | $5M | $-4M | $-11M | $-3M | $18M | $3M | $5M | |
| Taxes Paid | $7M | $7M | $4M | $-846.0K | $2M | $3M | $338.0K | $151.0K | |
| Free Cash Flow | $12M | $1M | $19M | $5M | $3M | $22M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.5% | 59.4% | 61.6% | 61.0% | 62.7% | 61.0% | · | · | |
| Operating Margin | 8.5% | 8.0% | 7.8% | 5.9% | 9.9% | 20.4% | · | · | |
| Net Margin | 5.5% | 5.0% | 5.6% | 4.5% | 7.8% | 24.0% | · | · | |
| Pretax Margin | 8.1% | 7.2% | 7.9% | 6.5% | 10.7% | 20.1% | · | · | |
| EBITDA Margin | 19.1% | 19.3% | 19.8% | 5.9% | 9.9% | 20.4% | · | · | |
| ROA | 7.9% | 6.8% | 7.5% | 5.3% | 7.9% | 32.3% | · | · | |
| ROE | 10.9% | 9.2% | 9.4% | 6.5% | 9.9% | 40.2% | · | · | |
| ROIC | 10.5% | 9.3% | 8.4% | 5.9% | 8.4% | 35.9% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.4 | 1.2 | 2.1 | 2.7 | 2.0 | · | · | |
| Quick Ratio | 1.0 | 1.1 | 1.0 | 1.7 | 2.3 | 1.9 | · | · | |
| Debt / Equity | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | · | · | |
| LT Debt / Equity | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.4 | 1.4 | 1.3 | 1.2 | 1.0 | 1.3 | · | · | |
| Inventory Turnover | 24.5 | 20.4 | 17.1 | 18.0 | 18.3 | 27.9 | · | · | |
| Receivables Turnover | 10.7 | 10.3 | 10.8 | 9.8 | 9.3 | 11.0 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.72 | $3.36 | $2.96 | $2.55 | $2.39 | $2.08 | · | · | |
| Revenue / Share | $6.62 | $5.50 | $4.53 | $3.49 | $2.88 | $3.24 | · | · | |
| Cash Flow / Share | $1.27 | $0.96 | $1.12 | $0.70 | $0.55 | $0.87 | · | · | |
| Cash / Share | $0.36 | $0.45 | $0.33 | $0.44 | $0.72 | $0.79 | · | · | |
| EPS (TTM) | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 | $0.78 | $0.21 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 20.5% | 22.5% | 31.8% | 18.6% | -10.8% | · | · | · | |
| Revenue CAGR 3Y | 24.9% | 24.2% | 11.7% | · | · | · | · | · | |
| Revenue CAGR 5Y | 15.5% | · | · | · | · | · | · | · | |
| EPS YoY | 32.1% | 12.0% | 56.2% | -27.3% | -71.8% | · | · | · | |
| EPS CAGR 3Y | 32.2% | 8.4% | -31.6% | · | · | · | · | · | |
| EPS CAGR 5Y | -13.9% | · | · | · | · | · | · | · | |
| Net Income YoY | 32.6% | 10.0% | 64.6% | -31.8% | -71.1% | · | · | · | |
| Net Income CAGR 3Y | 33.9% | 7.3% | -31.3% | · | · | · | · | · | |
| Net Income CAGR 5Y | -13.9% | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $270M | $224M | $183M | $139M | $117M | $131M | $80M | · | |
| Net Income TTM | $15M | $11M | $10M | $6M | $9M | $32M | $9M | · | |
| Market Cap | $282M | $314M | $302M | $288M | $207M | $304M | · | · | |
| Enterprise Value | $281M | $300M | $297M | $271M | $184M | $281M | · | · | |
| P/E | 20.1 | 28.6 | 31.4 | 47.2 | 23.7 | 9.9 | 29.5 | · | |
| P/S | 1.0 | 1.4 | 1.7 | 2.1 | 1.8 | 2.3 | · | · | |
| P/B | 2.0 | 2.4 | 2.7 | 3.0 | 2.2 | 3.7 | · | · | |
| P / Tangible Book | 3.5 | 3.2 | 3.6 | 3.0 | 2.2 | 3.7 | · | · | |
| P / Cash Flow | 5.4 | 8.0 | 6.7 | 10.4 | 9.2 | 8.7 | · | · | |
| P / FCF | 23.7 | 238.1 | 15.8 | 59.3 | 75.2 | 13.8 | · | · | |
| EV / EBITDA | 5.5 | 6.9 | 8.2 | 32.8 | 15.9 | 10.5 | · | · | |
| EV / FCF | 23.6 | 227.8 | 15.5 | 55.8 | 67.0 | 12.7 | · | · | |
| EV / Revenue | 1.0 | 1.3 | 1.6 | 2.0 | 1.6 | 2.1 | · | · | |
| Earnings Yield | 5.0% | 3.5% | 3.2% | 2.1% | 4.2% | 10.1% | 3.4% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $78M | $75M | $76M | $72M | $63M | $59M | $61M | $58M | $55M | $51M | $51M | $49M | $43M | $40M | $38M | $36M | |
| Cost of Revenue | $33M | $33M | $32M | $31M | $26M | $26M | $25M | $24M | $22M | $21M | $19M | $19M | $17M | $16M | $15M | $14M | |
| Gross Profit | $45M | $43M | $44M | $41M | $37M | $33M | $36M | $34M | $33M | $30M | $32M | $31M | $26M | $24M | $23M | $22M | |
| R&D Expense | $504.0K | $579.0K | $598.0K | $775.0K | $847.0K | $797.0K | $803.0K | $757.0K | $758.0K | $750.0K | $651.0K | $593.0K | $758.0K | $780.0K | $722.0K | $670.0K | |
| SG&A Expense | $37M | $35M | $32M | $32M | $29M | $28M | $28M | $27M | $27M | $25M | $24M | $24M | $21M | $20M | $17M | $18M | |
| Operating Income | $4M | $4M | $8M | $6M | $5M | $4M | $6M | $6M | $4M | $2M | $5M | $4M | $3M | $2M | $4M | $1M | |
| Other Non-op | $67.0K | $35.0K | $61.0K | $44.0K | $72.0K | $75.0K | $88.0K | $276.0K | $-563.0K | $26.0K | $-26.0K | $41.0K | $2.0K | $81.0K | $268.0K | $57.0K | |
| Pretax Income | $4M | $4M | $8M | $5M | $5M | $4M | $6M | $5M | $2M | $2M | $5M | $4M | $3M | $2M | $4M | $2M | |
| Income Tax | $1M | $1M | $2M | $2M | $2M | $952.0K | $2M | $2M | $768.0K | $518.0K | $2M | $1M | $728.0K | $501.0K | $1M | $456.0K | |
| Net Income | $3M | $3M | $6M | $4M | $3M | $3M | $4M | $4M | $1M | $2M | $3M | $3M | $2M | $2M | $2M | $1M | |
| EPS (Basic) | $0.07 | $0.07 | $0.14 | $0.09 | $0.08 | $0.07 | $0.11 | $0.10 | $0.04 | $0.04 | $0.09 | $0.08 | $0.06 | $0.04 | $0.07 | $0.03 | |
| EPS (Diluted) | $0.07 | $0.06 | $0.14 | $0.09 | $0.08 | $0.06 | $0.10 | $0.10 | $0.04 | $0.04 | $0.08 | $0.07 | $0.06 | $0.04 | $0.07 | $0.03 | |
| Shares (Basic) | 38,245,491 | 38,428,588 | · | 38,638,660 | 39,515,247 | 39,426,753 | · | 38,870,823 | 38,822,980 | 38,717,123 | · | 38,438,058 | 38,324,249 | 38,156,777 | · | 38,232,788 | |
| Shares (Diluted) | 41,125,716 | 40,491,298 | · | 40,495,761 | 41,083,760 | 41,627,876 | · | 40,779,414 | 40,553,449 | 40,580,634 | · | 40,420,615 | 40,676,951 | 40,016,693 | · | 39,583,438 | |
| EBITDA | $4M | $12M | · | $6M | $5M | $10M | · | $6M | $4M | $8M | · | $4M | $3M | $2M | · | $1M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $10M | $14M | $11M | $20M | $10M | $18M | $11M | $9M | $7M | · | $10M | $10M | $24M | · | $21M | |
| Receivables | $32M | $31M | $26M | $27M | $27M | $27M | $25M | $27M | $27M | $24M | · | $18M | $18M | $16M | · | $15M | |
| Inventory | $5M | $5M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | · | $5M | $4M | $3M | · | $3M | |
| Prepaid Expense | $6M | $4M | $4M | $4M | $4M | $8M | $6M | $5M | $4M | $2M | · | $3M | $2M | $3M | · | $3M | |
| Current Assets | $54M | $50M | $48M | $50M | $55M | $49M | $53M | $48M | $45M | $39M | · | $36M | $36M | $47M | · | $43M | |
| PP&E (Net) | $77M | $76M | $79M | $81M | $80M | $81M | $76M | $74M | $75M | $74M | · | $73M | $73M | $68M | · | · | |
| Accum. Depreciation | $65M | $63M | $61M | $58M | $54M | · | $58M | $57M | $58M | · | · | $50M | $45M | · | · | · | |
| Goodwill | $59M | $59M | $59M | $58M | $33M | $33M | $33M | $33M | $33M | $30M | · | $30M | $30M | · | · | · | |
| Intangibles | $1M | $1M | $1M | $1M | $783.0K | $816.0K | $848.0K | $880.0K | $912.0K | $534.0K | · | $688.0K | $688.0K | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | $0 | $0 | $887.0K | · | $887.0K | $887.0K | $2M | · | $2M | |
| Total Assets | $204M | $197M | $199M | $202M | $185M | $178M | $177M | $170M | $164M | $155M | · | $149M | $149M | $125M | · | $119M | |
| Accrued Liabilities | $25M | $22M | $24M | $25M | $19M | $18M | $20M | $20M | $17M | $14M | · | $17M | $16M | $13M | · | $12M | |
| Current Liabilities | $48M | $41M | $41M | $44M | $37M | $35M | $37M | $36M | $31M | $30M | · | $32M | $32M | $23M | · | $21M | |
| Capital Leases | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $215.0K | $143.0K | · | · | · | |
| Total Liabilities | $58M | $52M | $56M | $67M | $43M | $41M | $44M | $43M | $43M | $39M | · | $41M | $45M | $25M | · | $26M | |
| Long-term Debt | $7M | $9M | $12M | $21M | $4M | $4M | $4M | $4M | $9M | $7M | · | $10M | $15M | · | · | $4M | |
| Total Debt | $7M | $9M | · | $21M | $4M | $4M | · | $4M | $9M | $7M | · | $10M | $15M | · | · | $4M | |
| Common Stock | $18M | $21M | $17M | $17M | $28M | $28M | $23M | $23M | $22M | $22M | · | $19M | $18M | $17M | · | $15M | |
| Retained Earnings | $108M | $105M | $103M | $97M | $94M | $91M | $90M | $85M | $82M | $80M | · | $76M | $73M | $71M | · | $68M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $56.0K | |
| Stockholders' Equity | $144M | $144M | $142M | $134M | $140M | $135M | $131M | $125M | $119M | $116M | · | $109M | $105M | $100M | · | $94M | |
| Liabilities + Equity | $204M | $197M | $199M | $202M | $185M | $178M | $177M | $170M | $164M | $155M | · | $149M | $149M | $125M | · | $119M | |
| Shares Outstanding | 38,088,228 | 38,533,586 | 38,019,082 | 38,017,907 | 39,605,005 | 39,523,787 | 39,132,897 | 38,932,247 | 38,825,799 | 38,816,766 | 38,506,161 | 38,489,001 | 38,400,422 | 38,276,389 | 38,049,739 | 38,102,547 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $8M | $8M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | · | · | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Deferred Tax | · | · | $380.0K | $5M | · | · | $-333.0K | $-4M | $0 | $0 | $-648.0K | $-66.0K | $0 | $-725.0K | $1M | $0 | |
| Other Non-cash | · | $-5M | · | · | · | $-9M | · | · | · | $-8M | · | · | · | · | · | · | |
| Operating Cash Flow | $16M | $8M | $18M | $18M | $12M | $3M | $15M | $13M | $10M | $1M | $13M | $14M | $8M | $10M | $8M | $8M | |
| CapEx | $8M | $7M | $9M | $8M | $8M | $15M | $12M | $11M | $9M | $6M | $8M | $7M | $6M | $5M | $6M | $6M | |
| Investing Cash Flow | $-8M | $-5M | $-8M | $-32M | $-2M | $-9M | $-9M | $-5M | $-11M | $-5M | $-7M | $-9M | $-32M | $-4M | $-7M | $-6M | |
| Stock Repurchased | $5M | $1M | $0 | $12M | $2M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $710.0K | $2M | |
| Net Stock Activity | · | $-1M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-7M | $-6M | $-8M | $5M | $-671.0K | $-2M | $404.0K | $-5M | $2M | $-1M | $-3M | $-5M | $11M | $39.0K | $-5M | $-2M | |
| Net Change in Cash | $918.0K | $-4M | $2M | $-9M | $10M | $-7M | $6M | $3M | $1M | $-6M | $3M | $-146.0K | $-13M | $7M | $-5M | $-444.0K | |
| Taxes Paid | $359.0K | $14.0K | $123.0K | $208.0K | $4M | $3M | $411.0K | $3M | $4M | $0 | $348.0K | $125.0K | $3M | $-40.0K | $74.0K | $20.0K | |
| Free Cash Flow | · | $1M | · | · | · | $-13M | · | · | · | $-5M | · | · | · | $6M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.7% | 56.8% | · | 57.5% | 58.2% | 56.3% | · | 59.3% | 59.8% | 58.9% | · | 61.9% | 60.3% | 60.7% | · | 60.6% | |
| Operating Margin | 5.7% | 5.7% | · | 7.8% | 8.1% | 6.5% | · | 9.7% | 6.6% | 4.4% | · | 8.5% | 6.7% | 4.9% | · | 4.1% | |
| Net Margin | 3.5% | 3.4% | · | 4.9% | 5.0% | 4.4% | · | 6.7% | 2.7% | 3.2% | · | 5.9% | 5.4% | 3.8% | · | 2.9% | |
| Pretax Margin | 5.2% | 5.3% | · | 7.1% | 7.9% | 6.2% | · | 9.5% | 4.1% | 4.2% | · | 8.6% | 7.1% | 5.1% | · | 4.2% | |
| EBITDA Margin | 5.7% | 15.8% | · | 7.8% | 8.1% | 17.7% | · | 9.7% | 6.6% | 16.8% | · | 8.5% | 6.7% | 4.9% | · | 4.1% | |
| ROA | 1.4% | 1.4% | · | 1.9% | 1.8% | 1.6% | · | 2.4% | 0.94% | 1.1% | · | 2.2% | 1.8% | 1.2% | · | 0.90% | |
| ROE | 1.9% | 1.8% | · | 2.7% | 2.4% | 2.1% | · | 3.3% | 1.3% | 1.5% | · | 2.9% | 2.4% | 1.6% | · | 1.1% | |
| ROIC | 2.1% | 1.9% | · | 2.6% | 2.3% | 2.1% | · | 3.1% | 1.8% | 1.4% | · | 2.4% | 1.8% | 1.5% | · | 1.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.2 | · | 1.1 | 1.5 | 1.4 | · | 1.3 | 1.4 | 1.3 | · | 1.1 | 1.1 | 2.0 | · | 2.1 | |
| Quick Ratio | 0.9 | 1.0 | · | 0.9 | 1.2 | 1.0 | · | 1.1 | 1.1 | 1.1 | · | 0.9 | 0.9 | 1.7 | · | 1.8 | |
| Debt / Equity | 0.0 | 0.1 | · | 0.2 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | 0.0 | |
| LT Debt / Equity | 0.0 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | 0.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 6.9 | 6.7 | · | 6.4 | 6.0 | 5.8 | · | 5.3 | 5.0 | 5.3 | · | 4.8 | 4.7 | 5.2 | · | 4.9 | |
| Receivables Turnover | 2.7 | 2.6 | · | 2.6 | 2.4 | 2.3 | · | 2.6 | 2.4 | 2.5 | · | 3.0 | 2.7 | 2.6 | · | 2.6 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.78 | $3.73 | · | $3.51 | $3.53 | $3.41 | · | $3.21 | $3.07 | $3.00 | · | $2.83 | $2.72 | $2.61 | · | $2.46 | |
| Revenue / Share | $1.90 | $1.86 | · | $1.78 | $1.53 | $1.42 | · | $1.42 | $1.36 | $1.25 | · | $1.22 | $1.06 | $0.99 | · | $0.90 | |
| Cash Flow / Share | · | $0.20 | · | · | · | $0.07 | · | · | · | $0.03 | · | · | · | $0.26 | · | · | |
| Cash / Share | $0.28 | $0.25 | · | $0.29 | $0.51 | $0.26 | · | $0.29 | $0.23 | $0.19 | · | $0.26 | $0.27 | $0.62 | · | $0.56 | |
| EPS (TTM) | $0.36 | $0.37 | · | $0.33 | $0.34 | $0.30 | · | $0.26 | $0.23 | $0.25 | · | $0.24 | $0.20 | $0.16 | · | $0.19 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $302M | $287M | · | $255M | $241M | $233M | · | $214M | $206M | $194M | · | $170M | $156M | $146M | · | $133M | |
| Net Income TTM | $14M | $15M | · | $14M | $14M | $12M | · | $10M | $9M | $10M | · | $9M | $7M | $6M | · | $8M | |
| Market Cap | $434M | $355M | · | $258M | $274M | $288M | · | $285M | $254M | $366M | · | $259M | $376M | $370M | · | $229M | |
| Enterprise Value | $431M | $354M | · | $268M | $258M | $281M | · | $278M | $255M | $365M | · | $259M | $381M | · | · | $211M | |
| P/E | 31.7 | 24.9 | · | 20.6 | 20.3 | 24.3 | · | 28.2 | 28.5 | 37.7 | · | 28.0 | 48.9 | 60.4 | · | 31.6 | |
| P/S | 1.4 | 1.2 | · | 1.0 | 1.1 | 1.2 | · | 1.3 | 1.2 | 1.9 | · | 1.5 | 2.4 | 2.5 | · | 1.7 | |
| P/B | 3.0 | 2.5 | · | 1.9 | 2.0 | 2.1 | · | 2.3 | 2.1 | 3.1 | · | 2.4 | 3.6 | 3.7 | · | 2.4 | |
| P / Tangible Book | 5.2 | 4.2 | · | 3.5 | 2.6 | 2.9 | · | 3.1 | 3.0 | 4.3 | · | 3.3 | 5.1 | 3.7 | · | 2.4 | |
| P / Cash Flow | · | 44.0 | · | · | · | 100.8 | · | · | · | 311.5 | · | · | · | 35.2 | · | · | |
| EV / Revenue | 1.4 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.3 | 1.2 | 1.9 | · | 1.5 | 2.4 | · | · | 1.6 | |
| Earnings Yield | 3.2% | 4.0% | · | 4.9% | 4.9% | 4.1% | · | 3.5% | 3.5% | 2.6% | · | 3.6% | 2.0% | 1.7% | · | 3.2% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $270M | $224M | $183M | $139M | $117M |
| Bruttogewinnmarge % | 57.5% | 59.4% | 61.6% | 61.0% | 62.7% |
| Betriebsgewinnmarge % | 8.5% | 8.0% | 7.8% | 5.9% | 9.9% |
| Nettoergebnis | $15M | $11M | $10M | $6M | $9M |
| Verwässerte EPS | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 |
| Liquiditätsgrad | 1.2 | 1.4 | 1.2 | 2.1 | 2.7 |
| Quick Ratio | 1.0 | 1.1 | 1.0 | 1.7 | 2.3 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $12M | $1M | $19M | $5M | $3M |
Institutionelle Eigentümer (13F) 172 Einreicher · $304.9M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
172
Gehaltener Wert
$304.9M
Neue Positionen
28
Geschlossene Positionen
11
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 28 (-4 vs. Vorquartal) | 11 (0 vs. Vorquartal) | 67 (+16 vs. Vorquartal) | 36 (-3 vs. Vorquartal) | +1.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $54.586.700 | 4.788.307 | 17,90% | Aktien |
| Forager Capital Management, LLC | $24.409.498 | 2.141.184 | 8,01% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.067.106 | 1.321.676 | 4,94% | Aktien |
| GOLDMAN SACHS GROUP INC | $13.936.888 | 1.222.534 | 4,57% | Aktien |
| VANGUARD GROUP INC | $13.243.530 | 1.782.440 | 4,34% | Aktien |
| AMERIPRISE FINANCIAL INC | $11.470.623 | 1.006.195 | 3,76% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $11.102.817 | 973.744 | 3,64% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $8.963.467 | 786.269 | 2,94% | Aktien |
| STATE STREET CORP | $8.687.906 | 762.097 | 2,85% | Aktien |
| Nantahala Capital Management, LLC | $7.209.873 | 632.445 | 2,36% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $6.140.325 | 538.625 | 2,01% | Aktien |
| First Eagle Investment Management, LLC | $6.100.790 | 535.157 | 2,00% | Aktien |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | $6.081.512 | 533.466 | 1,99% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $5.002.901 | 438.851 | 1,64% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $4.855.260 | 425.900 | 1,59% | Aktien |
| Kent Lake PR LLC | $4.753.000 | 700.000 | 1,56% | Aktien |
| RAFFLES ASSOCIATES LP | $4.602.077 | 403.691 | 1,51% | Aktien |
| Creative Planning | $4.108.058 | 360.356 | 1,35% | Aktien |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $3.899.940 | 342.100 | 1,28% | Aktien |
| MARTIN & CO INC /TN/ | $3.884.789 | 340.771 | 1,27% | Aktien |
| BARD ASSOCIATES INC | $3.872.261 | 339.672 | 1,27% | Aktien |
| MORGAN STANLEY | $3.424.673 | 300.410 | 1,12% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.207.196 | 281.333 | 1,05% | Aktien |
| Penbrook Management LLC | $3.159.829 | 277.178 | 1,04% | Aktien |
| NORTHERN TRUST CORP | $3.093.538 | 271.363 | 1,01% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $2.992.340 | 262.486 | 0,98% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.699.406 | 236.790 | 0,89% | Aktien |
| CITADEL ADVISORS LLC | $2.671.191 | 234.315 | 0,88% | Aktien |
| Hillsdale Investment Management Inc. | $2.566.243 | 225.109 | 0,84% | Aktien |
| Expect Equity LLC | $2.425.019 | 212.721 | 0,80% | Aktien |
| RICE HALL JAMES & ASSOCIATES, LLC | $2.383.352 | 209.066 | 0,78% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $2.342.473 | 205.480 | 0,77% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $2.165.188 | 189.931 | 0,71% | Aktien |
| Walleye Capital LLC | $2.096.563 | 183.909 | 0,69% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.809.886 | 158.762 | 0,59% | Aktien |
| Point72 Asset Management, L.P. | $1.776.599 | 155.842 | 0,58% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.534.372 | 134.594 | 0,50% | Aktien |
| Cove Street Capital, LLC | $1.492.768 | 219.848 | 0,49% | Aktien |
| Quantinno Capital Management LP | $1.341.894 | 117.710 | 0,44% | Aktien |
| Nuveen, LLC | $1.327.997 | 116.491 | 0,44% | Aktien |
| JPMORGAN CHASE & CO | $1.266.134 | 111.162 | 0,42% | Aktien |
| FIRST TRUST ADVISORS LP | $1.262.116 | 110.712 | 0,41% | Aktien |
| SummerHaven Investment Management, LLC | $1.259.472 | 110.480 | 0,41% | Aktien |
| Informed Momentum Co LLC | $1.249.349 | 109.592 | 0,41% | Aktien |
| North Star Investment Management Corp. | $1.140.000 | 100.000 | 0,37% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.136.432 | 99.687 | 0,37% | Aktien |
| Man Group plc | $1.072.603 | 94.088 | 0,35% | Aktien |
| GABELLI FUNDS LLC | $1.053.360 | 92.400 | 0,35% | Aktien |
| Bank of New York Mellon Corp | $1.025.977 | 89.998 | 0,34% | Aktien |
| Trexquant Investment LP | $1.017.792 | 89.280 | 0,33% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Michael Moore, Moore Faster LLC ×4 Einreichungen | 24. September 2026 | 5,90% | Änderung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 13 Insider · 8 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Casey Hoyt | Chief Executive Officer | 29. Januar 2026 M | 350.464 | 0 | 0 | $0 |
| Trae Fitzgerald | Chief Financial Officer | 29. Januar 2026 M | 105.638 | 0 | 0 | $0 |
| Michael Moore | President | 20. März 2026 S | 1.585.812 | 0 | 3 | $-1.237.976 |
| William Todd Zehnder | Chief Operating Officer | 29. Januar 2026 M | 390.309 | 0 | 0 | $0 |
| William Frazier | Chief Medical Officer | 25. Juni 2026 M | 73.214 | 0 | 1 | $-117.200 |
| Jeremy Trahan | General Counsel | 29. Januar 2026 M | 46.492 | 0 | 0 | $0 |
| Jerome Cambre | Vice President of Sales | 29. Januar 2026 M | 104.088 | 0 | 0 | $0 |
| Eagan Ewell Patrick | General Counsel | 9. Mai 2023 M | 2.261 | 0 | 0 | $0 |
| Sabrina Heltz | Direktor | 17. August 2026 A | 82.520 | 0 | 0 | $0 |
| Nitin Kaushal | Direktor | 17. August 2026 A | 161.361 | 0 | 0 | $0 |
| Timothy Smokoff | Direktor | 17. August 2026 A | 90.547 | 0 | 5 | $-229.967 |
| Randy E. Dobbs | Direktor | 17. August 2026 A | 142.253 | 0 | 0 | $0 |
| Bruce D Greenstein | Direktor | 25. August 2024 M | 76.651 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 18 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SAWS · ETF Series Solutions | 1,41% | 9.437 NS | 31. Juli 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,32% | 16.912 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,07% | 114.570 SH | 11. September 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 10.775 SH | 2. Oktober 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 36.563 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 319.961 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 16.188 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 196.637 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 854.188 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 24.560 SH | 2. Oktober 2026 | Täglich |
| DFIS · Dimensional ETF Trust | 0,00% | 5.448 NS | 31. Juli 2026 | N-PORT |
| DFIC · Dimensional ETF Trust | 0,00% | 9.492 NS | 31. Juli 2026 | N-PORT |
| DFSI · Dimensional ETF Trust | 0,00% | 723 NS | 31. Juli 2026 | N-PORT |
| DFAX · Dimensional ETF Trust | 0,00% | 6.272 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 11.992 SH | 3. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 380.753 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 912.713 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.259 SH | 19. August 2026 | Täglich |
VMD Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 7 Analysten
KAUF
Median-Ziel
$12.50
+36,9%
2 28,6%
Starker Kauf
3 42,9%
Kauf
2 28,6%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-10-01Mittelwert-Ziel $12.50 +36,9%
← Unter allen Zielen
Aktueller Preis $9.13
Tief$11.00
Mittelwert$12.50
Hoch$14.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Killer-Fälschungen: Flohmittel, die Sie zum Tierarzt rennen lassen könnten
The Guardian · 4 Monate, 2 Wochen vor
Viemed Healthcare hebt Wachstum, Diversifizierung und Prognose für 2026 auf Investorenkonferenz hervor
Yahoo Finance · 6 Monate, 1 Woche vor
1 Gesundheitsaktie, die Gewinne direkt zu Ihnen nach Hause bringt
Yahoo Finance · 6 Monate, 2 Wochen vor
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 3, 2026